Skip to search form
Skip to main content
Skip to account menu
Semantic Scholar
Semantic Scholar's Logo
Search 233,238,913 papers from all fields of science
Search
Sign In
Create Free Account
GIPR gene
Known as:
INSULINOTROPIC POLYPEPTIDE RECEPTOR, GLUCOSE-DEPENDENT
, Gastric Inhibitory Polypeptide Receptor Gene
, GASTRIC INHIBITORY POLYPEPTIDE RECEPTOR
Expand
This gene is involved in G protein-coupled receptor signal transduction and may play a role in glucocorticoid and anabolic metabolism.
National Institutes of Health
Create Alert
Alert
Related topics
Related topics
7 relations
G Protein-Coupled Receptor Signaling
Gastric Inhibitory Polypeptide Receptor, human
Ligand Binding
Protein Secretion
Expand
Papers overview
Semantic Scholar uses AI to extract papers important to this topic.
Review
2019
Review
2019
Glucose-Dependent Insulinotropic Polypeptide Receptor Therapies For The Treatment Of Obesity, Do Agonists = Antagonists?
Elizabeth A. Killion
,
Shu-Chen Lu
,
M. Fort
,
Yuichiro Yamada
,
M. Véniant
,
D. Lloyd
Endocrine reviews
2019
Corpus ID: 202563211
Glucose-dependent insulinotropic polypeptide (GIP) receptor (GIPR) is associated with obesity in human genome-wide association…
Expand
2017
2017
Peptide dual agonists of gipr and glp2r
B. Hartmann
,
M. Gabe
,
L. Gasbjerg
,
M. Rosenkilde
,
J. Holst
2017
Corpus ID: 104443472
2017
2017
The expression of glucose-dependent insulinotropic polypeptide receptor (GIPR) and insulin receptor (IR) in mouse taste cells
T. Shingo
,
Ninomiya Yuzo
,
Shigemura Noriatsu
2017
Corpus ID: 90609084
2015
2015
[Erratum] Effects of glucose-dependent insulinotropic polypeptide receptor knockout and a high-fat diet on cognitive function and hippocampal gene expression in mice.
Rachael Lennox
,
R. Moffett
,
David W. Porter
,
N. Irwin
,
V. Gault
,
P. Flatt
Molecular Medicine Reports
2015
Corpus ID: 32582696
It has been previously demonstrated that compromise of glucose-dependent insulinotropic polypeptide receptor (GIPR) action and…
Expand
2012
2012
Identifying Biomarkers of Subclinical Diabetes
R. Kulkarni
Diabetes
2012
Corpus ID: 6675729
The epidemic of type 2 diabetes and the ever-increasing economic burden on society is a constant reminder of the continuing need…
Expand
2012
2012
Bedeutung genetischer Polymorphismen in GCKR, GIPR, ADCY5 und VPS13C für die Therapie-Effektivität von Sulfonylharnstoffen und das Risiko schwerer Hypoglykämien
Jd Holstein
,
O. Patzer
,
A. Körner
,
M. Stumvoll
,
P. Kovács
,
A. Holstein
2012
Corpus ID: 76367909
2010
2010
Élucidation des mécanismes moléculaires impliqués dans l’expression aberrante du récepteur au peptide insulinotropique glucose-dépendant (GIP) dans les tumeurs du cortex de la glande surrénale
Antoine Lampron
2010
Corpus ID: 57446107
2009
2009
Analysis of glucose-dependent insulinotropic peptide receptor (GIPR) and luteinizing hormone receptor (LHCGR) expression in human adrenocortical hyperplasia.
M. H. Costa
,
S. Domenice
,
+5 authors
M. Fragoso
Arquivos brasileiros de endocrinologia e…
2009
Corpus ID: 5292556
OBJECTIVE To analyze the aberrant expression of the GIPR and LHCGR in different forms of adrenocortical hyperplasia: ACTH…
Expand
2002
2002
ANALYSIS OF THE PUTATIVE PROMOTER REGION OF THE GIP RECEPTOR GENE (GIPR) IN GIP-DEPENDENT CUSHING'S SYNDROME (CS)
S. Antonini
,
N. N'diaye
,
P. Hamet
,
J. Tremblay
,
A. Lacroix
Endocrine Research
2002
Corpus ID: 21467413
GIP-dependent Cushing’s syndrome (CS) has been reported in patients with either unilateral adrenal adenoma or bilateral…
Expand
Review
2002
Review
2002
Clinical and pathological characterization of a novel transgenic animal model of diabetes mellitus expressing a dominant negative glucose-dependent insulinotropic polypeptide receptor (GIPR dn)
N. Herbach
2002
Corpus ID: 83665973
Clinical and pathological characterization of a novel transgenic animal model of diabetes mellitus expressing a dominant negative…
Expand
By clicking accept or continuing to use the site, you agree to the terms outlined in our
Privacy Policy
(opens in a new tab)
,
Terms of Service
(opens in a new tab)
, and
Dataset License
(opens in a new tab)
ACCEPT & CONTINUE